Eli Lilly and Company vs HSBC Holdings plc
Eli Lilly and Company is worth $1.061T, 3.0× the $355.195B market cap of HSBC Holdings plc. Updated daily.
| Metric | ||
|---|---|---|
| Market cap | $1.061T | $355.195B |
| Global rank | #1 | #2 |
| Share price | $1,189.41 | $103.65 |
| Change | -2.11% | +0.43% |
| Revenue | $65.179B | $71.020B |
| Net income | $20.640B | $22.285B |
| Country | United States | United Kingdom |
| Sector | Healthcare | Financial Services |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Eli Lilly and Company bigger than HSBC Holdings plc?
- Eli Lilly and Company has a market cap of $1.061T against $355.195B for HSBC Holdings plc, making it 3.0 times as valuable.
- Which company earns more, LLY or HSBC?
- Eli Lilly and Company reported net income of $20.640B and HSBC Holdings plc reported $22.285B in their most recent annual periods.

